Aerami Therapeutics today announced positive data supporting its inhaled imatinib for treating pulmonary hypertension (PH). Studies of AER-901 support progression into a Phase 2 clinical trial. Data backed Aerami’s treatment for both PH associated with interstitial lung disease (PH-ILD) and pulmonary arterial hypertension (PAH). AER-901 is a drug-device combination. Aerami designed it to deliver potentially […]
Pharmaceuticals
FDA approves another nasal spray for treating opioid overdose
The FDA approved Opvee nalmefene hydrochloride nasal spray for the emergency treatment of opioid overdoses from Opiant Pharmaceuticals. Approval covers the treatment of known or suspected opioid overdose in adults and pediatric patients 12 years of age and older. This market the first such authorization for this type of spray in healthcare and community use. […]
Schott Pharma launches pre-filled polymer syringes for deep-cold drugs
Schott Pharma announced today that it launched pre-fillable syringes made from advanced polymers for delivering deep-cold drugs. These deep-cold drugs are stored and transported on dry ice at temperatures reaching -100°C. Schott designed the syringes from an advanced, pharmaceutical-grade polymer, delivered in a standardized nest and tub configuration. This ensures compatibility on major fill-finish lines […]
Micron Biomedical raises $17M for needle-free drug delivery tech
Micron Biomedical announced today that it added $3 million to its Series A, bringing the total funding to $17 million. Atlanta-based Micron develops dissolvable, microarray-based products to simplify the delivery of drugs and vaccines. J2 Ventures provided the additional $3 million. J2 Ventures Partner Dr. Matt Goldman joins Micron’s board as an observer following the […]
This technology could enable time-released drug delivery
Bioengineers at Rice University developed a new technology for delivering drugs in a time-releasing manner. Kevin McHugh, corresponding author of a study about the technology, believes this could make missing doses of medicines and vaccines a thing of the past. McHugh and the Rice team saw their work published online in Advanced Materials. According to McHugh […]
Medtech veteran Tatyana Beldock joins Dyve Biosciences board
Dyve Biosciences announced today that Tatyana Beldock joined the company’s board of directors. Camarillo, California-based Dyve develops the DMAX delivery platform. Its transdermal drug delivery technology directly targets the acidic microenvironments that drive cancer cell growth and inflammation. “We are thrilled to have Tatyana join our board,” said Dr. Ryan Beal, CEO of Dyve. “Tatyana brings […]
Study backs self-administration with Vaxxas vaccine patch
Vaxxas today announced clinical trial data demonstrating the potential of its high-density microarray patch (HD-MAP) for vaccine delivery. The company published the data highlighting effective vaccine payload delivery in Human Vaccines & Immunotherapeutics. This counts for both trained professionals and individual self-administration. Vaxxas reported an equivalency of observed human skin response and vaccine delivery potential between […]
FDA approves over-the-counter Narcan nasal spray
The FDA announced today that it approved Narcan 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter, nonprescription use. Narcan rapidly reverses the effects of opioid overdose and remains the standard treatment for such an overdose. Approval allows direct-to-consumer sales in places like drug stores, convenience stores and more. The FDA nod comes about six […]
This implantable drug delivery system is self-powered
Researchers at Shirley Ryan AbilityLab and Northwestern University developed technology that uses external light sources to trigger drug delivery. Yamin Zhang and Dr. Colin Franz of Shirley Ryan and John Rogers of Northwestern led the research team. They say their technology represents the first implantable drug delivery system triggered by external light sources. These light […]
Rani Therapeutics beats Street EPS estimates in Q4
Rani Therapeutics (Nasdaq:RANI) shares dipped on fourth-quarter results that just managed to beat the consensus EPS forecast. Shares of RANI fell 4.2% at $5.70 apiece in midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — dipped 0.6%. The San Jose, California-based robotic pill maker posted […]
